The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis

Infection

Volumn 36, Issue 3, 2008, Pages 213-219

  Schmit, X ^a   Vincent, J L ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PREDNISOLONE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PROTEIN BLOOD LEVEL; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; SEPSIS; TREATMENT RESPONSE;

AGED; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYCOSES; PROGNOSIS; SEPSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 45849104786     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-7077-9     Document Type: Article

References (27)

1. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D: Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34: 344-353.
2. Valles J, Rello J, Ochagavia A, Garnacho J, Alcala MA: Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003; 123: 1615-1624.
3. MacArthur RD, Miller M, Albertson T, Panacek E, Johnson D, Teoh L, Barchuk W: Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis 2004; 38: 284-288.
4. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D: Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115: 529-535.
5. Parham P: The immune system. Garland Publishing, New York, 2000.
6. Tillett WS, Francis T Jr: Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930; 52: 561-571.
7. Vigushin DM, Pepys MB, Hawkins PN: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91: 351-1357.
8. Pepys MB, Baltz ML: Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 41-212.
9. Hogarth MB, Gallimore R, Savage P, Palmer AJ, Starr JM, Bulpitt CJ, Pepys MB: Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient. Age Ageing 1997; 26: 153-158.
10. Jaye DL, Waites KB: Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997; 16: 735-746.
11. Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H: C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005; 11: 101-108.
12. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C, Vincent JL: C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003; 123: 2043-2049.
13. Presterl E, Staudinger T, Pettermann M, Lassnigg A, Burgmann H, Winkler S, Frass M, Graninger W: Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med 1997; 156: 825-832.
14. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003; 31: 1250-1256.
15. Vincent JL, Moreno R, Takala J, Willatts S, de Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22: 707-710.
16. Vincent JL: Dear Sirs, I'm sorry to say that I don't like you. Crit Care Med 1997; 25: 372-374.
17. Pittet D, Thiévent B, Wenzel RP, Li N, Gurman G, Suter PM: Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 1993; 19: 265-272.
18. Clapp BR, Hirschfield GM, Storry C, Gallimore JR, Stidwill RP, Singer M, Deanfield JE, MacAllister RJ, Pepys MB, Vallance P, Hingorani AD: Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 2005; 111: 1530-1536.
19. Mineo C, Gormley AK, Yuhanna IS, Osborne-Lawrence S, Gibson LL, Hahner L, Shohet RV, Black S, Salmon JE, Samols D, Karp DR, Thomas GD, Shaul PW: FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase. Circ Res 2005; 97: 1124-1131.
20. Ferard G, Gaudias J, Bourguignat A, Ingenbleek Y: C-reactive protein to transthyretin ratio for the early diagnosis and follow-up of postoperative infection. Clin Chem Lab Med 2002; 40: 1334-1338.
21. Ugarte H, Silva E, Mercan D, de Mendonça A, Vincent JL: Procalcitonin as a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498-504.
22. Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H: Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Crit Care 2006; 10: R63.
23. Reny JL, Vuagnat A, Ract C, Benoit MO, Safar M, Fagon JY: Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 2002; 30: 529-535.
24. Clec'h C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, Cohen Y: Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004; 32: 1166-1169.
25. Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH: C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 1995; 108: 1288-1291.
26. Persson L, Soderquist B, Engervall P, Vikerfors T, Hansson LO, Tidefelt U: Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur J Haematol 2005; 74: 297-303.
27. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396-402.